Physio-Control said today it agreed to acquire North Irish automated external defibrillator manufacturer HeartSine Technologies for an undisclosed amount. The 2 companies said they completed due diligence but have not released details of the transaction or dates the acquisition is slated to close. “With Physio-Control and HeartSine now united in our lifesaving missions, we will […]
physiocontrol
Physio-Control, Aircraft Medical sign distro deal
Physio-Control said today it inked a deal with Aircraft Medical to distribute its McGrath MAC EMS video laryngoscope internationally. U.K.-based Aircraft Medical’s laryngoscope is a traditional macintosh design, with the addition of video, providing both direct and indirect laryngeal views, the company said. “The most common feedback on the product is its ease of use, […]
FDA to require PMAs for automated external defibrillators
Former Medtronic emergency response unit Physio-Control buys Sansio
Teleflex affirms 2012 guidance | Wall Street Beat
Teleflex (NYSE:TFX) said yesterday that it expects its 2012 earnings to meet Wall Street’s expectations, but forecast softer profits for the coming year.
The Limerick, Pa.-based medical device company said its "preliminary financial goals" for 2013 are for sales growth of 11%-13% and adjusted EPS of $4.70-$4.90.
MassDevice.com +7 | The top 7 med-tech stories for the week of January 29, 2012.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
MassDevice.com +3 | The top 3 med-tech stories for January 30, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Medtronic closes $478M Physio-Control sale to Bain Capital
Medtronic, Inc. (NYSE:MDT) today closed the sale of its Physio-Control defibrillator business to Bain Capital for $478 million in cash.
The deal, first announced in November 2011, included the promotion of Brian Webster from president to CEO of newly independent automated external defibrillator maker.
Physio-Control secures extension of $49M military contract
Physio-Control won an extension of its $49.4 million military contract with the U.S. Dept. of Defense for its automated external defibrillators and related accessories.
The Redmond, Wash.-based company was one of 61 bidders for the contract, which supplies the the Army, Navy, Air Force, Marine Corps, Veterans Admin., and federal civilian agencies. The contract ends Dec. 7, 2016, according to the Defense Dept.
UPDATE: Medtronic finally unloads Physio-Control
Less than a month after new CEO Omar Ishrak signaled Medtronic’s (NYSE:MDT) continued interest in selling its troublesome Physio-Control resuscitation business, the company found a buy ready to put nearly half a billion dollars on the table: private equity firm Bain Capital.
FLASH: Medtronic unloads Physio Control to Bain Capital for $478 million
Medtronic, Inc. (NYSE:MDT) agreed to sell its Physio-Control external defibrillator subsidiary to Bain Capital for roughly $478 million in cash.
"Medtronic expects to use a portion of the proceeds to offset any potential dilutive impact from this transaction to fiscal year 2012 non-GAAP earnings per share," the company said in a press release.
Stay tuned to MassDevice.com for more on this breaking story.